Tumor Heterogeneity Predicts Metastatic Potential in Colorectal Cancer
暂无分享,去创建一个
Woo Yong Lee | Joon Seol Bae | Je-Gun Joung | Yong Beom Cho | Woong-Yang Park | Y. Cho | W. Lee | W. Park | Hae-Ock Lee | Je-Gun Joung | B. Oh | H. Hong | H. Al-Khalidi | Faisal Al-alem | J. Bae | Jinho Kim | H. Cha | Maram Alotaibi | M. Hassanain | Bo Young Oh | Hae-Ock Lee | Hye Kyung Hong | Mazen Hassanain | Hisham Al-Khalidi | Faisal Al-Alem | Jinho Kim | Hong-Ui Cha | Maram Alotaibi
[1] Steven J. M. Jones,et al. Comprehensive molecular characterization of human colon and rectal cancer , 2012, Nature.
[2] A. Bouchard-Côté,et al. PyClone: statistical inference of clonal population structure in cancer , 2014, Nature Methods.
[3] B. Giusti,et al. EXCAVATOR: detecting copy number variants from whole-exome sequencing data , 2013, Genome Biology.
[4] Vladimir Vacic,et al. Comparative sequencing analysis reveals high genomic concordance between matched primary and metastatic colorectal cancer lesions , 2014, Genome Biology.
[5] Noemi Andor,et al. EXPANDS: expanding ploidy and allele frequency on nested subpopulations , 2013, Bioinform..
[6] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.
[7] B. Taylor,et al. deconstructSigs: delineating mutational processes in single tumors distinguishes DNA repair deficiencies and patterns of carcinoma evolution , 2016, Genome Biology.
[8] Richard Durbin,et al. Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .
[9] A. Jemal,et al. Cancer statistics, 2014 , 2014, CA: a cancer journal for clinicians.
[10] Obi L. Griffith,et al. SciClone: Inferring Clonal Architecture and Tracking the Spatial and Temporal Patterns of Tumor Evolution , 2014, PLoS Comput. Biol..
[11] C. Meijer,et al. Somatic mutation in PIK3CA is a late event in cervical carcinogenesis , 2015, The journal of pathology. Clinical research.
[12] Yu Cao,et al. Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing , 2014, Science.
[13] E. Mroz,et al. Intra-tumor Genetic Heterogeneity and Mortality in Head and Neck Cancer: Analysis of Data from The Cancer Genome Atlas , 2015, PLoS medicine.
[14] G Smith,et al. The prognostic significance of K-ras, p53, and APC mutations in colorectal carcinoma , 2005, Gut.
[15] L. Foroni,et al. Notch-1 Mutations Are Secondary Events in Some Patients with T-Cell Acute Lymphoblastic Leukemia , 2007, Clinical Cancer Research.
[16] Y. Samuels,et al. Oncogenic mutations of PIK3CA in human cancers. , 2004, Current topics in microbiology and immunology.
[17] Z. Szallasi,et al. Spatial and temporal diversity in genomic instability processes defines lung cancer evolution , 2014, Science.
[18] M. DePristo,et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. , 2010, Genome research.
[19] A. McKenna,et al. Evolution and Impact of Subclonal Mutations in Chronic Lymphocytic Leukemia , 2012, Cell.
[20] Y. Cho,et al. Animal models of colorectal cancer with liver metastasis. , 2017, Cancer letters.
[21] David T. W. Jones,et al. Signatures of mutational processes in human cancer , 2013, Nature.
[22] M. D'Angelica,et al. Meeting the biologic challenge of colorectal metastases , 2012, Clinical & Experimental Metastasis.
[23] C. Curtis,et al. A Big Bang model of human colorectal tumor growth , 2015, Nature Genetics.
[24] Céline Lefebvre,et al. Comparative analysis of primary tumour and matched metastases in colorectal cancer patients: evaluation of concordance between genomic and transcriptional profiles. , 2015, European journal of cancer.
[25] Xinbing Sui,et al. Use of Metformin Alone Is Not Associated with Survival Outcomes of Colorectal Cancer Cell but AMPK Activator AICAR Sensitizes Anticancer Effect of 5-Fluorouracil through AMPK Activation , 2014, PloS one.
[26] N. McGranahan,et al. Inferring mutational timing and reconstructing tumour evolutionary histories. , 2015, Biochimica et biophysica acta.
[27] T. Efferth,et al. Tumor Heterogeneity, Single-Cell Sequencing, and Drug Resistance , 2016, Pharmaceuticals.